Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

The #ALS space—and the HEALEY ALS Platform Trial—saw two more failures this week, from Denali Therapeutics and AbbVie/Calico Life Sciences. After a disappointing 2024 for the space ...

Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained ...

The multi-centre, placebo-controlled, double-blind trial will assess the therapy’s safety, pharmacodynamics, efficacy, and pharmacokinetics in adult ALS patients. Sean M Healey & AMG Centre for ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb ...

failed to show efficacy in part of the phase 2/3 HEALEY ALS basket trial, causing a fall in its share price. The South San Francisco biotech announced that eIF2B agonist DNL343 was unable to slow ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

The agreement, signed Friday on one of the last days of the Biden administration, reduces the total cost owed to the federal government by about $1 billion The Healey administration has reached a ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

The first celebrity has been voted off Dancing On Ice and if you missed the episode, you might be wondering who will hang their skates up. Soap star Chelsee Healey said she had the “best time ...